Study links Edwards' transcatheter heart valve to higher survival rate

09/22/2010 | Washington Post, The

A study of 358 patients who need heart valve replacements but are not candidates for open-heart surgery showed that 30% of those who were implanted with Edwards Lifesciences' transcatheter aortic valve died a year after, compared with half of those who didn't receive the device. However, the study showed that valve recipients were more likely to have strokes than those who didn't get the device.

View Full Article in:

Washington Post, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC